Okadaic Acid Induces Tau Phosphorylation in SH-SY5Y Cells in an Estrogen-preventable Manner

Overview

Journal Brain Res

Specialty Neurology

Date 2010 May 12

PMID 20457142

Citations 28

Authors

Zhang Zhang

James W Simpkins

Affiliations

Soon will be listed here.

Abstract

One of the pathological hallmarks of Alzheimer's disease (AD) is neurofibrillary tangles (NFTs), which are composed of abnormally hyperphosphorylated tau, but the mechanism of tau hyperphosphorylation in AD is still unclear. To investigate the effects of estrogens on tau phosphorylation, SH-SY5Y cells were treated with okadaic acid (OA), a serine/threonine phosphatase inhibitor, to induce tau phosphorylation and the effects of estrogen were observed by co-treatment with 17beta-estradiol (E2). We found that OA induced in vitro tau hyperphosphorylation, which was prevented by E2 in a dose-dependent manner. This effect of E2 was partially blocked by an estrogen receptor (ER) antagonist, ICI 182,780. In addition to tau hyperphosphorylation, inhibition of serine/threonine phosphorylation induced upregulation of cdk5 levels, which was attenuated by E2 in a manner that was counteracted by ICI 182,780. Our results show that cdk5 is involved in OA-induced tau hyperphosphorylation, and estrogens ameliorate the tau hyperphosphorylation, which may be mediated in part by ER.

Citing Articles

Comparative Study of Injected Alzheimer's Disease Models in Rats: Insights from Experimental Research.

Doumar H, Mostafi H, Elhessni A, Laaziz A, Mesfioui A Pathophysiology. 2024; 31(4):643-659.

PMID: 39585164 PMC: 11587412. DOI: 10.3390/pathophysiology31040047.

Felodipine attenuates neuroinflammatory responses and tau hyperphosphorylation through JNK/P38 signaling in tau-overexpressing AD mice.

Hwang J, Kim J, Park J, Nam J, Jang J, Jo A Mol Brain. 2024; 17(1):62.

PMID: 39223564 PMC: 11367747. DOI: 10.1186/s13041-024-01137-y.

A Review of the Role of Estrogens in Olfaction, Sleep and Glymphatic Functionality in Relation to Sex Disparity in Alzheimer's Disease.

Ekanayake A, Peiris S, Ahmed B, Kanekar S, Grove C, Kalra D Am J Alzheimers Dis Other Demen. 2024; 39:15333175241272025.

PMID: 39116421 PMC: 11311174. DOI: 10.1177/15333175241272025.

Hydroxyethyl-Modified Cycloheptatriene-BODIPY Derivatives as Specific Tau Imaging Probes.

Li Y, Tian C, Xie T, Zhang Q, Liu J, Yan X ACS Med Chem Lett. 2023; 14(8):1108-1112.

PMID: 37583810 PMC: 10424304. DOI: 10.1021/acsmedchemlett.3c00248.

Sex-based differences in effector cells of the adaptive immune system during Alzheimer's disease and related dementias.

Lutshumba J, Wilcock D, Monson N, Stowe A Neurobiol Dis. 2023; 184:106202.

PMID: 37330146 PMC: 10481581. DOI: 10.1016/j.nbd.2023.106202.

References

Mudher A, Lovestone S . Alzheimer's disease-do tauists and baptists finally shake hands?. Trends Neurosci. 2002; 25(1):22-6. DOI: 10.1016/s0166-2236(00)02031-2. View

Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S . Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 1993; 325(3):167-72. DOI: 10.1016/0014-5793(93)81066-9. View

Baudier J, Cole R . Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J Biol Chem. 1987; 262(36):17577-83. View

Green P, Simpkins J . Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci. 2000; 18(4-5):347-58. DOI: 10.1016/s0736-5748(00)00017-4. View

Ballatore C, Lee V, Trojanowski J . Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci. 2007; 8(9):663-72. DOI: 10.1038/nrn2194. View

Bang O, Hong H, Kim D, Kim H, Boo J, Huh K . Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis. 2004; 16(1):21-8. DOI: 10.1016/j.nbd.2003.12.017. View

Gong C, Shaikh S, Wang J, Zaidi T, Grundke-Iqbal I, Iqbal K . Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem. 1995; 65(2):732-8. DOI: 10.1046/j.1471-4159.1995.65020732.x. View

Gong C, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K . Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem. 2000; 275(8):5535-44. DOI: 10.1074/jbc.275.8.5535. View

Goedert M, Spillantini M, Jakes R, Rutherford D, Crowther R . Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 1989; 3(4):519-26. DOI: 10.1016/0896-6273(89)90210-9. View

10.

Arias C, Sharma N, Davies P . Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J Neurochem. 1993; 61(2):673-82. DOI: 10.1111/j.1471-4159.1993.tb02172.x. View

11.

Arendt T, Holzer M, Bruckner M, Janke C, Gartner U . The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease. Neuroscience. 1998; 85(4):1337-40. DOI: 10.1016/s0306-4522(97)00697-0. View

12.

Ihara Y, Nukina N, Miura R, Ogawara M . Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J Biochem. 1986; 99(6):1807-10. DOI: 10.1093/oxfordjournals.jbchem.a135662. View

13.

Devred F, Barbier P, Douillard S, Monasterio O, Andreu J, Peyrot V . Tau induces ring and microtubule formation from alphabeta-tubulin dimers under nonassembly conditions. Biochemistry. 2004; 43(32):10520-31. DOI: 10.1021/bi0493160. View

14.

Ekinci F, Ortiz D, Shea T . Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel. Brain Res Mol Brain Res. 2003; 117(2):145-51. DOI: 10.1016/s0169-328x(03)00294-8. View

15.

Filley C . Alzheimer's disease in women. Am J Obstet Gynecol. 1997; 176(1 Pt 1):1-7. DOI: 10.1016/s0002-9378(97)80003-8. View

16.

Lee M, Kwon Y, Li M, Peng J, Friedlander R, Tsai L . Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 2000; 405(6784):360-4. DOI: 10.1038/35012636. View

17.

Johnson G, Stoothoff W . Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci. 2004; 117(Pt 24):5721-9. DOI: 10.1242/jcs.01558. View

18.

Sergeant N, Delacourte A, Buee L . Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta. 2004; 1739(2-3):179-97. DOI: 10.1016/j.bbadis.2004.06.020. View

19.

Yi K, Covey D, Simpkins J . Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J Neurochem. 2008; 108(3):732-40. PMC: 2727740. DOI: 10.1111/j.1471-4159.2008.05805.x. View

20.

Liu M, Choi S, Cuny G, Ding K, Dobson B, Glicksman M . Kinetic studies of Cdk5/p25 kinase: phosphorylation of tau and complex inhibition by two prototype inhibitors. Biochemistry. 2008; 47(32):8367-77. DOI: 10.1021/bi800732v. View